ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,034, issued on Feb. 17, was assigned to EYESTEM RESEARCH PRIVATE Ltd. (Ahmedabad, India).

"Unified in-vitro process for obtaining lung cells from pluripotent stem cells" was invented by Rajarshi Pal (Bengaluru, India), Harshini Bava Surendran (Bangalore, India) and Mohanapriya Rajamoorthy (Tamil Nadu Dharmapuri, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is an in-vitro protocol for differentiating human induced pluripotent stem cells (hiPSCs) or human embryonic stem cells (hESC) to give rise to a definitive endoderm, followed by progression into anteriorized foregut endoderm that has the ability to give rise to both proximal and ...